February 12, 2019

Horiba, Ltd   
Naoyuki Nomura   
Medical Segment Strategy Office Assistant Section Leader   
2 Miyanohigashi, Kisshoin, Minami-ku   
Kyoto, 601-8510   
Japan

Re: K183375 Trade/Device Name: Yumizen C1200 Glucose HK Sodium Electrode Potassium Electrode Chloride Electrode Yumizen C1200 Regulation Number: 21 CFR 862.1345 Regulation Name: Glucose test system Regulatory Class: Class II Product Code: CFR, JGS, CEM, CGZ, JJE Dated: November 30, 2018 Received: December 6, 2018

Dear Naoyuki Nomura:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- 1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice   
(https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn   
(http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

# Sincerely, Kellie B. Kelm -S

Courtney H. Lias, Ph.D.IRU Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

Device Name Yumizen C1200, Yumizen C1200 Glucose HK, Sodium Electrode, Potassium Electrode, Chloride Electrode

Indications for Use (Describe)

The Yumizen C1200 Glucose HK reagent is intended for the quantitative in vitro diagnostic determination of glucose in human serum, plasma, and urine using a glucose hexokinase method by colorimetry. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia, and pancreatic islet cell carcinoma.

The sodium electrode is an ion selective electrode that is intended for use on the ion selective electrode (ISE) unit of the Yumizen C1200 analyzer. The sodium electrode is used to quantify the concentrations of sodium ions in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of aldosteronism (excessive secretion of the hormone aldosterone), diabetes insipidus (chronic excretion of large amounts of dilute urine, accompanied by extreme thirst), adrenal hypertension, Addison’s disease (caused by destruction of the adrenal glands), dehydration, inappropriate antidiuretic hormone secretion, or other diseases involving electrolyte imbalance.

The potassium electrode is an ion selective electrode that is intended for use on the ion selective electrode (ISE) unit of the Yumizen C1200 analyzer. The potassium electrode is used to quantify the concentrations of potassium ions in serum, plasma, and urine. Measurements obtained by this device are used to monitor electrolyte balance in the diagnosis and treatment of diseases and conditions characterized by low or high blood potassium levels.

The chloride electrode is an ion selective electrode that is intended for use on the ion selective electrode (ISE) unit of the Yumizen C1200 analyzer. The chloride electrode is used to quantify the concentrations of chloride ions in serum, plasma, and urine. Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

The Yumizen C1200 is an automatic chemistry analyzer that measures analytes in samples, in combination with appropriate reagents, calibrators, quality control (QC) material and other accessories. Applications include colorimetric and ion selective electrode. This analyzer is intended for professional use in a laboratory environment only. Tests performed using this analyzer are intended for in vitro diagnostic use.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

# \*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

“An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number.”

# 510(k) SUMMARY

"This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92." "The assigned 510(k) number is: k183375.

Date of Summary: 02/08/2019

Product Name Yumizen C1200

Sponsor   
HORIBA, Ltd.   
2 Miyanohigashi, Kisshoin, Minami-ku, Kyoto 601-8510, Japan

# Correspondent

Naoyuki Nomura   
2 Miyanohigashi, Kisshoin, Minami-ku, Kyoto 601-8510, Japan   
+81-80-4358-0440   
naoyuki.nomura@horiba.com

# Device Trade or Proprietary Name

1. Clinical Chemistry Analyzer   
Trade/Proprietary Name: Yumizen C1200   
Common or Usual Name: Clinical Chemistry Analyzer   
Device Class: Class I   
Regulation: $\ S 8 6 2 . 2 1 6 0$   
Classification Name: Discrete photometric chemistry analyzer for clinical use   
Product Code: JJE: Analyzer, Chemistry (Photometric, Discrete), For   
Clinical Use   
Review Panel Clinical Chemistry

2. Glucose Trade/Proprietary Name: Yumizen C1200 Glucose HK Common or Usual Name: Glucose HK Device Class: Class II Regulation: §862.1345 Classification Name: Glucose test system Product Code: CFR: Hexokinase, Glucose Review Panel Clinical Chemistry

3. ISE module   
Trade/Proprietary Name: Sodium Electrode   
Common or Usual Name: Sodium Electrode   
Device Class: Class II   
Regulation: $\ S 8 6 2 . 1 6 6 5$   
Classification Name: Sodium test system   
Product Code: JGS: Electrode, Ion Specific, Sodium   
Review Panel Clinical Chemistry   
Trade/Proprietary Name: Potassium Electrode   
Common or Usual Name: Potassium Electrode   
Device Class: Class II   
Regulation: $\ S 8 6 2 . 1 6 0 0$   
Classification Name: Potassium test system   
Product Code: CEM: Electrode, Ion Specific, Potassium   
Review Panel Clinical Chemistry   
Trade/Proprietary Name: Chloride Electrode   
Common or Usual Name: Chloride Electrode   
Device Class: Class II   
Regulation: $\ S 8 6 2 . 1 1 7 0$   
Classification Name: Chloride test system   
Product Code: CGZ: Electrode, Ion-Specific, Chloride   
Review Panel Clinical Chemistry

<table><tr><td rowspan=1 colspan=1>Investigational Device</td><td rowspan=1 colspan=1>Primary Predicate Device name</td><td rowspan=1 colspan=1>Primary predicate devicemanufacturer</td><td rowspan=1 colspan=1>k number</td></tr><tr><td rowspan=1 colspan=1>Yumizen C1200</td><td rowspan=1 colspan=1>DxC 700 AU Clinical Chemistry Analyzer</td><td rowspan=1 colspan=1>Beckman Coulter, Inc.</td><td rowspan=1 colspan=1>k161837</td></tr><tr><td rowspan=1 colspan=1>Yumizen C1200 Glucose HK</td><td rowspan=1 colspan=1>ABX PENTRA Glucose HK CP on Pentra C400CLINICAL CHEMISTRY ANALYZER</td><td rowspan=1 colspan=1>HORIBA ABX SAS</td><td rowspan=1 colspan=1>k081276</td></tr><tr><td rowspan=1 colspan=1>Sodium Electrode</td><td rowspan=3 colspan=1>ISE reagents on DxC 700 AU Clinical Chemistry Analyzer</td><td rowspan=3 colspan=1>Beckman Coulter, Inc.</td><td rowspan=3 colspan=1>k161837</td></tr><tr><td rowspan=1 colspan=1>Potassium Electrode</td></tr><tr><td rowspan=1 colspan=1>Chloride Electrode</td></tr></table>

1. Device Comparison between Yumizen C1200 and DxC 700 AU Clinical Chemistry Analyzer table   

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Primary Predicate Device nameDxC 700 AU Clinical Chemistry Analyzerk161837</td><td rowspan=1 colspan=1>Investigational DeviceYumizen C1200</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Manufactured by</td><td rowspan=1 colspan=1>Beckman Coulter, Inc.</td><td rowspan=1 colspan=1>JEOL Ltd.</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Instrument type</td><td rowspan=1 colspan=1>Stand type</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Work station</td><td rowspan=1 colspan=1>Separate</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Throughput</td><td rowspan=1 colspan=1>Without ISE: 800 tests/hWith ISE :1200 tests/h</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Sample treatment</td><td></td><td rowspan=1 colspan=1>′</td></tr><tr><td rowspan=1 colspan=1>Sample type</td><td rowspan=1 colspan=1>Serum, Plasma, Urine, Cerebrospinal fluid (CSF)</td><td rowspan=1 colspan=1>Serum, Plasma, Urine</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Sample input</td><td rowspan=1 colspan=1>Sample rack, STAT Table, Direct-line SampleAspiration (For Automation Connections)</td><td rowspan=1 colspan=1>Sample tray, STAT Table</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Sample volume</td><td rowspan=1 colspan=1>1.0 to 25.0 µL</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Parameters on board</td><td rowspan=1 colspan=1>60 photometric tests + 3 ISEs</td><td rowspan=1 colspan=1>45 photometric tests + 3 ISEs</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Sample capacity</td><td rowspan=1 colspan=1>150 (15 racks × 10 samples)</td><td rowspan=1 colspan=1>84 (2 Sample tray × 42 samples)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Bar-code reader</td><td rowspan=1 colspan=1>Integrated</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Dilution of patient sample</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Reagent</td><td></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Type of reagent</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1></td></tr></table>

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Primary Predicate Device nameDxC 700 AU Clinical Chemistry Analyzerk161837</td><td rowspan=1 colspan=1>Investigational DeviceYumizen C1200</td></tr><tr><td rowspan=1 colspan=1>Refrigerated</td><td rowspan=1 colspan=1>Reagent 1: 60 bottles capacityReagent 2: 48 bottles capacity</td><td rowspan=1 colspan=1>Reagent 1: 45 bottles capacityReagent 2: 45 bottles capacity</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Sample Analysis</td><td></td></tr><tr><td rowspan=1 colspan=1>Total reaction volume</td><td rowspan=1 colspan=1>Min: 120 µL, Max: 350 µL</td><td rowspan=1 colspan=1>Min: 80 µL, Max: 430 µL</td></tr><tr><td rowspan=2 colspan=1>Cuvette material</td><td rowspan=1 colspan=1>Glass</td><td rowspan=1 colspan=1>Plastic</td></tr><tr><td rowspan=1 colspan=1>Washable cuvettes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Number of cuvette</td><td rowspan=1 colspan=1>165</td><td rowspan=1 colspan=1>231</td></tr><tr><td rowspan=3 colspan=1>Wave length</td><td rowspan=1 colspan=1>Halogen lamp</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>340 to 800 nm</td><td rowspan=1 colspan=1>340 to 884 nm</td></tr><tr><td rowspan=1 colspan=1>13 wavelengths: 340, 380, 410, 450, 480, 520,540,570, 600, 660, 700, 750 and 800 nm (maximum of 2wavelengths)</td><td rowspan=1 colspan=1>14 wavelengths: 340, 410, 451, 478, 505,545, 571, 596, 658, 694, 751, 805, 845 and884 nm (maximum of 2 wavelengths)</td></tr><tr><td rowspan=1 colspan=1>Type of measurement</td><td rowspan=1 colspan=1>Endpoint assayReaction rate assayFixed point assayElectrode method (ISE)</td><td rowspan=1 colspan=1>Endpoint assay (EPA)Reaction rate assay (RRA)2-point assay (2PA)Constant rate assay (CRA)Immunoassay (IMA)Electrode method (ISE)</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Physical characteristics</td><td></td></tr><tr><td rowspan=1 colspan=1>Dimensions(WxDxH)</td><td rowspan=1 colspan=1>1250 × 890 mm × 1300 mm</td><td rowspan=1 colspan=1>1220 × 850 × 1108 mm</td></tr><tr><td rowspan=1 colspan=1>Weight</td><td rowspan=1 colspan=1>465 kg</td><td rowspan=1 colspan=1>450 kg</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Primary Predicate Device NameABX Pentra Glucose HK CPk081276</td><td colspan="1" rowspan="1">Investigational DeviceYumizen C1200 Glucose HK</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">HORIBA ABX SAS</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">b</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Pentra C400 CLINICAL CHEMISTRY ANALYZER</td><td colspan="1" rowspan="1">Yumizen C1200</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Method</td><td colspan="1" rowspan="1">Enzymatic method using hexokinase coupled withglucose-6-phosphate dehydrogenase</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Sample type</td><td colspan="1" rowspan="1">Serum, Plasma, Urine</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">b</td></tr><tr><td colspan="1" rowspan="1">Reagent format</td><td colspan="1" rowspan="1">Liquid</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="3">Measuring Range</td><td colspan="1" rowspan="1">Serum: 0.11 - 50.00 mmol/L1.98 - 900.00 mg/dL</td><td colspan="1" rowspan="1">Serum: 0.10 - 35.00 mmol/L1.8 - 630.0 mg/dL</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Urine: 0.22 - 50.00 mmol/L3.96 - 900.0 mg/dL</td><td colspan="1" rowspan="1">Urine: 0.47 - 35.0 mmol/L8.5 - 630 .0 mg/dL</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Automatic post-dilution:Up to 150.00 mmol/L2700 mg/dL</td><td colspan="1" rowspan="1">Automatic post-dilution:Up to 140.00 mmol/L2520 mg/dL</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="2">Packaging</td><td colspan="1" rowspan="2">Reagent 1: 56 mLReagent 2: 14 mL</td><td colspan="1" rowspan="1">Reagent 1: 6 x 39 mLReagent 2: 6 × 13 mL</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="1">Reagent 1: 4 × 57 mLReagent 2: 3 × 26 mL</td></tr><tr><td colspan="1" rowspan="1">Calibrators</td><td colspan="1" rowspan="1">ABX PENTRA Multical</td><td colspan="1" rowspan="1">Yumizen C1200 Multical</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="4">Controls</td><td colspan="1" rowspan="1">ABX PENTRA N Control</td><td colspan="1" rowspan="1">Yumizen C1200 N Multi Control</td><td colspan="1" rowspan="1">′</td></tr><tr><td colspan="1" rowspan="1">ABX PENTRA P Control</td><td colspan="1" rowspan="1">Yumizen C1200 P Multi Control</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="2">ABX PENTRA Urine Control L/H</td><td colspan="1" rowspan="1">Yumizen C1200 Urine Level 1 Control</td><td colspan="1" rowspan="4"></td></tr><tr><td colspan="1" rowspan="1">Yumizen C1200 Urine Level 2 Control</td></tr><tr><td colspan="1" rowspan="2">Reagent stability</td><td colspan="1" rowspan="1">Open: Stable for 55 days on board</td><td colspan="1" rowspan="1">Open: Stable for 6 weeks on board</td></tr><tr><td colspan="1" rowspan="1">Closed: Stable up to the expiry date on the label if storedat 2-8C.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Primary Predicate Device nameISE reagents on DxC 700 AU Clinical ChemistryAnalyzerk161837</td><td colspan="1" rowspan="1">Investigational DeviceYumizen C1200</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ISE parameters</td><td colspan="1" rowspan="1">NA, K, CL</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">′</td><td colspan="1" rowspan="1">Potentiometry</td><td colspan="1" rowspan="1">Indirect</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Sample volume</td><td colspan="1" rowspan="1">20 µL for 3 parameters</td><td colspan="1" rowspan="1">22 µL for 3 parameters</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Sodium Electrode</td><td colspan="1" rowspan="1">Crown ether membrane</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Potassium Electrode</td><td colspan="1" rowspan="1">Crown ether membrane</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Chloride Electrode</td><td colspan="1" rowspan="1">Super-layer solid molecule orientation membrane</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="6"></td><td colspan="1" rowspan="1">Reference Electrode</td><td colspan="1" rowspan="1">Sealed silver/silver chloride electrode</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="5">Reagent</td><td colspan="1" rowspan="1">ISE Buffer Solution</td><td colspan="1" rowspan="1">ISE Buffer (IS)</td></tr><tr><td colspan="1" rowspan="1">ISE Mid Standard Solution</td><td colspan="1" rowspan="3">Internal Standard</td></tr><tr><td colspan="1" rowspan="1">ISE Reference Solution</td></tr><tr><td colspan="1" rowspan="1">ISE Internal Reference Solution</td></tr><tr><td colspan="1" rowspan="1">Na+/K+ Selectivity Check Solution</td><td></td></tr><tr><td></td><td colspan="1" rowspan="3">Calibrator</td><td colspan="1" rowspan="1">Low Serum Standard</td><td colspan="1" rowspan="2">ISE Serum Standard Set (NA)</td></tr><tr><td></td><td colspan="1" rowspan="1">High Serum Standard</td></tr><tr><td></td><td colspan="1" rowspan="1">Low/High Urine Standard</td><td colspan="1" rowspan="1">ISE Urine Standard Set</td></tr><tr><td></td><td colspan="1" rowspan="1">Measurement</td><td colspan="1" rowspan="1">Quantitative</td><td colspan="1" rowspan="1">Same</td></tr><tr><td></td><td colspan="1" rowspan="1">Sample Type</td><td colspan="1" rowspan="1">Serum, Plasma, Urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td></td><td colspan="1" rowspan="8">Measuring range</td><td colspan="1" rowspan="1">Serum</td><td></td></tr><tr><td></td><td colspan="1" rowspan="1">NA 50 - 200 mmol/L</td><td colspan="1" rowspan="1">NA 100 - 200 mmol/L</td></tr><tr><td></td><td colspan="1" rowspan="1">K 1.0 - 10.0 mmol/L</td><td colspan="1" rowspan="1">K 1.5 - 10 mmol/L</td></tr><tr><td></td><td colspan="1" rowspan="1">CL 50 - 200 mmol/L</td><td colspan="1" rowspan="1">CL 52 - 200 mmol/L</td></tr><tr><td></td><td colspan="1" rowspan="1">Urine</td><td></td></tr><tr><td></td><td colspan="1" rowspan="1">NA 10 - 400 mmol/L</td><td colspan="1" rowspan="1">NA 10 - 400 mmol/L</td></tr><tr><td></td><td colspan="1" rowspan="1">K 2.0 - 200.0 mmol/L</td><td colspan="1" rowspan="1">K 3 - 300 mmol/L</td></tr><tr><td></td><td colspan="1" rowspan="1">CL 15 - 400 mmol/L</td><td colspan="1" rowspan="1">CL 15 - 400 mmol/L</td></tr></table>

# Intended Use

# 1. Yumizen C1200 Glucose HK

The Yumizen C1200 Glucose HK reagent is intended for the quantitative in vitro diagnostic determination of glucose in human serum, plasma, and urine using a glucose hexokinase method by colorimetry. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia, and pancreatic islet cell carcinoma.

2. ISE module

This ISE unit is designed for making quantitative measurements of Na (sodium), K (potassium), and Cl (chloride) in serum, plasma, and urine samples. This unit is intended for professional use in a laboratory environment only.

# 2.1 Sodium Electrode

The sodium electrode is an ion selective electrode that is intended for use on the ion selective electrode (ISE) unit of the Yumizen C1200 analyzer. The sodium electrode is used to quantify the concentrations of sodium ions in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of aldosteronism (excessive secretion of the hormone aldosterone), diabetes insipidus (chronic excretion of large amounts of dilute urine, accompanied by extreme thirst), adrenal hypertension, Addison’s disease (caused by destruction of the adrenal glands), dehydration, inappropriate antidiuretic hormone secretion, or other diseases involving electrolyte imbalance.

2.2 Potassium Electrode

The potassium electrode is an ion selective electrode that is intended for use on the ion selective electrode (ISE) unit of the Yumizen C1200 analyzer. The potassium electrode is used to quantify the concentrations of potassium ions in serum, plasma, and urine. Measurements obtained by this device are used to monitor electrolyte balance in the diagnosis and treatment of diseases and conditions characterized by low or high blood potassium levels.

2.3 Chloride Electrode

The chloride electrode is an ion selective electrode that is intended for use on the ion selective electrode (ISE) unit of the Yumizen C1200 analyzer. The chloride electrode is used to quantify the concentrations of chloride ions in serum, plasma, and urine. Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

3. Yumizen C1200

The Yumizen C1200 is an automatic chemistry analyzer that measures analytes in samples, in combination with appropriate reagents, calibrators, quality control (QC) material and other accessories. Applications include colorimetric and ion selective electrode. This analyzer is intended for professional use in a laboratory environment only. Tests performed using this analyzer are intended for in vitro diagnostic use.

# Methodology

1. The chemistry principles of Operations The operation principle of Yumizen C1200 system is as follows

![](images/8baf2eac21afe70cfc0563ee8d84c159a587d9ee5f69cad0008d7a5b92d4e6e1.jpg)

The reagent probe (RPP) dispenses reagent 1 (R1) from reagent tray 1 (RTT1) to a clean reaction cuvette on the reaction carousel (RRV).

The sample probe (SPP) dispenses the sample in the quantity required for the test from the sample tray (STT) into the RRV now containing R1.

Sample dilution is possible if necessary. The diluent is placed in the RTT and dispensed into the reaction cuvette. Next, the sample is dispensed into the same cuvette by the SPP and mixed with the mixing rod. Now the diluted sample is in the reaction cuvette. The SPP dispenses the diluted sample in the reaction cuvette in which R1 required for the test has already been dispensed. The dispensed sample and R1 are mixed in the reaction cuvette. Next, reagent 2/2 early (e) is dispensed from the RTT as required. The contents are then mixed for the length of time required by the test. Photometric measurement data is collected by the spectrophotometer every 13.5 seconds to calculate concentration at each measurement point, which are posted to the workstation. The reaction cuvettes are washed with detergent and tepid water and blank measurement is performed for each wavelength.

# 2. The measuring assay of glucose

Glucose is phosphorylated by hexokinase (HK) in the presence of adenosine triphosphate (ATP) and magnesium ions to produce glucose-6-phospage (G-6- P) and adenosine diphosphate (ADP). Glucose-6-phosphate dehydrogenase (G-6-PDH) specifically oxidizes G-6-P to 6-phosphogluconate with the concurrent reduction of nicotinamide adenine dinucleotide $( N A D ^ { + } )$ to nicotinamide adenine dinucleotide(NADH), reduced. The change in absorbance at 340/410 nm is proportional to the amount of glucose present in the sample.

![](images/f3ac7a5730bc84220fce3d282d31e67776356b6a6af5764c269f3959f34ac017.jpg)

3. The measuring assay of Electrodes

The ISE module employs membrane electrodes for sodium, potassium and chloride that are specific for each ion of interest in the sample. An electrical potential is developed according to the Nernst Equation for a specific ion. When compared to the Internal Solution, this electrical potential is translated into voltage and then into the ion concentration of the sample.

Each of the selected electrodes is composed of the following membrane

$\checkmark$ NA: Crown ether membrane   
$\checkmark$ K: Crown ether membrane   
$\checkmark$ CL: Super-layer solid molecule orientation membrane

# Performance Data

1. Yumizen C1200 Glucose HK

1.1 Measuring Range

The limit of detection and quantitation was determined according to the CLSI guideline EP17-A2.   
The reagent linearity was determined according to CLSI guideline EP06-A.

The limit of quantitation and the linearity studies showed that claimed measuring ranges are appropriate.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Limit of quantitation</td><td rowspan=1 colspan=1>Measuring range</td></tr><tr><td rowspan=1 colspan=1>Serum / plasma</td><td rowspan=1 colspan=1>1.8 mg/dL0.10 mmol/L</td><td rowspan=1 colspan=1>1.8 to630.0 mg/dL0.10to35.00mmol/L</td></tr><tr><td rowspan=1 colspan=1>Urine</td><td rowspan=1 colspan=1>3.5 mg/dL0.19 mmol/L</td><td rowspan=1 colspan=1>8.5 to630.0mg/dL0.47 to35.00mmol/L</td></tr><tr><td rowspan=1 colspan=1>Post-dilution</td><td rowspan=1 colspan=1>NA</td><td rowspan=1 colspan=1>In serum /plasma /urineUp to 2520.0 mg/dLUp to 140.00 mmol/L</td></tr></table>

1.2 Accuracy and Precision 1.2.1 Repeatability (within-run precision) 2 level controls and 5 samples of low, middle, and high concentrations were tested 20 times.   

<table><tr><td rowspan=3 colspan=1></td><td rowspan=1 colspan=4>Serum</td><td rowspan=1 colspan=4>Urine</td></tr><tr><td rowspan=1 colspan=2>Mean value</td><td rowspan=1 colspan=2>CV %</td><td rowspan=1 colspan=2>Mean value</td><td rowspan=1 colspan=2>CV %</td></tr><tr><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mmol/L</td></tr><tr><td rowspan=1 colspan=1>Control N</td><td rowspan=1 colspan=1>91.91</td><td rowspan=1 colspan=1>5.106</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>23.85</td><td rowspan=1 colspan=1>1.325</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>Control P</td><td rowspan=1 colspan=1>275.02</td><td rowspan=1 colspan=1>15.278</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>294.27</td><td rowspan=1 colspan=1>16.348</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>Sample 1</td><td rowspan=1 colspan=1>9.92</td><td rowspan=1 colspan=1>0.551</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>11.13</td><td rowspan=1 colspan=1>0.617</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0.8</td></tr><tr><td rowspan=1 colspan=1>Sample 2</td><td rowspan=1 colspan=1>30.80</td><td rowspan=1 colspan=1>1.711</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>17.07</td><td rowspan=1 colspan=1>0.949</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.9</td></tr><tr><td rowspan=1 colspan=1>Sample 3</td><td rowspan=1 colspan=1>96.52</td><td rowspan=1 colspan=1>5.362</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>178.71</td><td rowspan=1 colspan=1>9.928</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.5</td></tr><tr><td rowspan=1 colspan=1>Sample 4</td><td rowspan=1 colspan=1>272.07</td><td rowspan=1 colspan=1>15.115</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>353.08</td><td rowspan=1 colspan=1>19.616</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.8</td></tr><tr><td rowspan=1 colspan=1>Sample 5</td><td rowspan=1 colspan=1>556.09</td><td rowspan=1 colspan=1>30.894</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>570.28</td><td rowspan=1 colspan=1>31.682</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>0.6</td></tr></table>

1.2.2 Reproducibility (total precision) 2 level controls and 5 patient samples of low, middle and high level concentrations were tested in duplicate for 20 days (2 series per day) according to the CLSI guideline EP05-A3.   

<table><tr><td rowspan=3 colspan=1></td><td rowspan=1 colspan=4>Serum</td><td rowspan=1 colspan=4>Urine</td></tr><tr><td rowspan=1 colspan=2>Mean value</td><td rowspan=1 colspan=2>CV %</td><td rowspan=1 colspan=2>Mean value</td><td rowspan=1 colspan=2>CV %</td></tr><tr><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mmol/L</td></tr><tr><td rowspan=1 colspan=1>Control N</td><td rowspan=1 colspan=1>92.70</td><td rowspan=1 colspan=1>5.150</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>25.04</td><td rowspan=1 colspan=1>1.391</td><td rowspan=1 colspan=1>4.0</td><td rowspan=1 colspan=1>4.0</td></tr><tr><td rowspan=1 colspan=1>Control P</td><td rowspan=1 colspan=1>255.24</td><td rowspan=1 colspan=1>14.180</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>279.65</td><td rowspan=1 colspan=1>15.536</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>3.1</td></tr><tr><td rowspan=1 colspan=1>Sample 1</td><td rowspan=1 colspan=1>12.65</td><td rowspan=1 colspan=1>0.703</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>11.87</td><td rowspan=1 colspan=1>0.660</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>3.6</td></tr><tr><td rowspan=1 colspan=1>Sample 2</td><td rowspan=1 colspan=1>30.63</td><td rowspan=1 colspan=1>1.702</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>16.64</td><td rowspan=1 colspan=1>0.924</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>3.4</td></tr><tr><td rowspan=1 colspan=1>Sample 3</td><td rowspan=1 colspan=1>103.56</td><td rowspan=1 colspan=1>5.753</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>174.80</td><td rowspan=1 colspan=1>9.711</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>3.2</td></tr><tr><td rowspan=1 colspan=1>Sample 4</td><td rowspan=1 colspan=1>259.29</td><td rowspan=1 colspan=1>14.405</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>324.70</td><td rowspan=1 colspan=1>18.039</td><td rowspan=1 colspan=1>3.3</td><td rowspan=1 colspan=1>3.3</td></tr><tr><td rowspan=1 colspan=1>Sample 5</td><td rowspan=1 colspan=1>571.87</td><td rowspan=1 colspan=1>31.770</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>537.47</td><td rowspan=1 colspan=1>29.859</td><td rowspan=1 colspan=1>4.3</td><td rowspan=1 colspan=1>4.3</td></tr></table>

# 1.3 Interferences

The Interferences were determined according to the CLSI guideline EP07-A2.

lculated bias was within the $10 \%$ acceptance criteria on serum and urine samples for up to the following concentrations.

<table><tr><td rowspan=1 colspan=2>Serum</td><td rowspan=1 colspan=2>Urine</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>501 mg/dL (290 μmol/L)</td><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>501 mg/dL (290 μmol/L)</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>569 mg/dL (6.50 mmol/L)</td><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>27.20 mg/dL (465 μmol/L)</td></tr><tr><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>35.53 mg/dL (607 µmol/L)</td><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>5.98 mg/dL (340 µmol/L)</td></tr><tr><td rowspan=1 colspan=1>Direct Bilirubin</td><td rowspan=1 colspan=1>21.09 mg/dL (360 μmol/L)</td><td rowspan=1 colspan=1>Modification of the pH ofthe samples</td><td rowspan=1 colspan=1>No impact on glucose assaymeasurement</td></tr><tr><td rowspan=1 colspan=1>AcetylsalicylicAcid</td><td rowspan=1 colspan=1>65.16 mg/dL (3.62 mmol/L)</td><td rowspan=1 colspan=1>Specific gravity</td><td rowspan=1 colspan=1>1.000 - 1.030</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>5.98 mg/dL (340 µmol/L)</td><td rowspan=3 colspan=2></td></tr><tr><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>50.1 mg/dL (2.43 mmol/L)</td></tr><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>20 mg/dL (1324 µmol/L)</td></tr></table>

1.4 Matrix comparison on predicate device

This protocol was according to the CLSI guideline EP09-A3. 56 plasma samples were evaluated on Yumizen C1200 using Yumizen C1200 Glucose HK reagent and with the Pentra C400 Clinical Chemistry Analyzer with ABX PENTRA Glucose HK reagent (Predicate device). The equation for the regression line using Passing Bablok was obtained.

<table><tr><td rowspan=1 colspan=1>Passing Bablok</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Correlation - r</td></tr><tr><td rowspan=1 colspan=1>Glucose in plasma (mg/dL)</td><td rowspan=2 colspan=1>56</td><td rowspan=1 colspan=1>-0.070</td><td rowspan=1 colspan=1>0.991</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>Glucose in plasma (mmol/L)</td><td rowspan=1 colspan=1>0.013</td><td rowspan=1 colspan=1>0.988</td><td rowspan=1 colspan=1>0.999</td></tr></table>

1.5 Method comparison with a predicate device

Yumizen C1200 was compared with Pentra C400 Clinical Chemistry Analyzer. 140 (in serum) and 100 (in urine) patient samples were correlated with a commercial reagent taken as reference according to the CLSI guideline EP09-A3. The equation for the regression line using Passing Bablok was obtained.

<table><tr><td rowspan=1 colspan=1>Passing Bablok</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Correlation - r</td></tr><tr><td rowspan=1 colspan=1>Glucose in serum (mg/dL)</td><td rowspan=1 colspan=1>141</td><td rowspan=1 colspan=1>-2.453</td><td rowspan=1 colspan=1>1.005</td><td rowspan=1 colspan=1>0.996</td></tr><tr><td rowspan=1 colspan=1>Glucose in urine (mg/dL)</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0.975</td><td rowspan=1 colspan=1>1.007</td><td rowspan=1 colspan=1>0.999</td></tr></table>

1.6 Reagent Stability

1.6.1 Closed stability

The closed stability was determined according to the CLSI guideline EP25-A.

Stable up to the expiry date on the label if stored at 2 - 8 degree C.

1.6.2 Open stability

Stable up to the expiry date on the label if stored at the refrigerated compartment is stable for 6 weeks.

1.7 Reference Range

The Reference Range was determined according to the CLSI guideline EP28-A3c.

50 normal samples (25 women $\boldsymbol { + 2 5 }$ men) in serum were assayed with the method in evaluation. Each sample was assayed in duplicates. The mean of the duplicate results for each subject was compared against reference ranges cited in literature. The verification studied support in the following reference ranges which were established through literature.

Serum: 70 to $1 1 5 \mathrm { m g / d L }$ (3.89 to 6.39 mmol/L)

Reference

Thomas L. Clinical Laboratory Diagnostics. 1st ed. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 131-7, 1368.

2 ISE module on Yumizen C1200

2.1 Measuring Range   
The measuring range of the Sodium, Potassium and Chloride Electrodes on Yumizen C1200 was validated by the linearity .studies.

<table><tr><td rowspan=1 colspan=1>Parameters</td><td rowspan=1 colspan=1>Measuring range</td></tr><tr><td rowspan=1 colspan=1>NA in serum(mmol/L)</td><td rowspan=1 colspan=1>100 to 200</td></tr><tr><td rowspan=1 colspan=1>K inserum(mmol/L)</td><td rowspan=1 colspan=1>1.5 to10</td></tr><tr><td rowspan=1 colspan=1>CL inn serum(mmol/L)</td><td rowspan=1 colspan=1>52 to200</td></tr><tr><td rowspan=1 colspan=1>NA inurine(mmol/L)</td><td rowspan=1 colspan=1>10 to400</td></tr><tr><td rowspan=1 colspan=1>K inurine(mmol/L)</td><td rowspan=1 colspan=1>3 to 300</td></tr><tr><td rowspan=1 colspan=1>CL in urine(mmol/L)</td><td rowspan=1 colspan=1>15 to 400</td></tr></table>

# 2.2 Accuracy and Precision

2.2.1 Repeatability (within-run precision) The Repeatability was determined by analyzing 2 level controls, 3 samples of low, middle and high level concentration and the spiked samples were tested 20 times by 3 reagent Lots.   

<table><tr><td colspan="2" rowspan="2">Control in serum</td><td colspan="3" rowspan="1">Control N</td><td colspan="3" rowspan="1">Control P</td><td colspan="3" rowspan="1">Control N2</td><td colspan="3" rowspan="1">Control P2</td></tr><tr><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td></tr><tr><td colspan="1" rowspan="2">NA</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">133.80</td><td colspan="1" rowspan="1">134.68</td><td colspan="1" rowspan="1">134.55</td><td colspan="1" rowspan="1">134.55</td><td colspan="1" rowspan="1">135.37</td><td colspan="1" rowspan="1">135.84</td><td colspan="1" rowspan="1">122.13</td><td colspan="1" rowspan="1">123.10</td><td colspan="1" rowspan="1">123.25</td><td colspan="1" rowspan="1">154.39</td><td colspan="1" rowspan="1">155.18</td><td colspan="1" rowspan="1">154.66</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td></tr><tr><td colspan="1" rowspan="2">K</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">4.296</td><td colspan="1" rowspan="1">4.336</td><td colspan="1" rowspan="1">4.333</td><td colspan="1" rowspan="1">6.643</td><td colspan="1" rowspan="1">6.689</td><td colspan="1" rowspan="1">6.700</td><td colspan="1" rowspan="1">3.825</td><td colspan="1" rowspan="1">3.865</td><td colspan="1" rowspan="1">3.866</td><td colspan="1" rowspan="1">6.536</td><td colspan="1" rowspan="1">6.567</td><td colspan="1" rowspan="1">6.553</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.1</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="2">CL</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">114.04</td><td colspan="1" rowspan="1">115.47</td><td colspan="1" rowspan="1">114.24</td><td colspan="1" rowspan="1">112.75</td><td colspan="1" rowspan="1">114.50</td><td colspan="1" rowspan="1">113.45</td><td colspan="1" rowspan="1">91.21</td><td colspan="1" rowspan="1">91.70</td><td colspan="1" rowspan="1">91.64</td><td colspan="1" rowspan="1">112.01</td><td colspan="1" rowspan="1">112.17</td><td colspan="1" rowspan="1">111.72</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="2">Pa</td><td colspan="1" rowspan="1">Patient sample</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Low sample</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">M</td><td colspan="1" rowspan="1">ddle sam</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">High sample</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Spiked sample</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">in serum</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td></tr><tr><td colspan="1" rowspan="2">NA</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">125.85</td><td colspan="1" rowspan="1">126.81</td><td colspan="1" rowspan="1">126.74</td><td colspan="1" rowspan="1">138.64</td><td colspan="1" rowspan="1">139.61</td><td colspan="1" rowspan="1">139.18</td><td colspan="1" rowspan="1">148.72</td><td colspan="1" rowspan="1">149.51</td><td colspan="1" rowspan="1">148.84</td><td colspan="1" rowspan="1">165.20</td><td colspan="1" rowspan="1">165.83</td><td colspan="1" rowspan="1">164.90</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="2">K</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">2.773</td><td colspan="1" rowspan="1">2.779</td><td colspan="1" rowspan="1">2.784</td><td colspan="1" rowspan="1">4.041</td><td colspan="1" rowspan="1">4.067</td><td colspan="1" rowspan="1">4.065</td><td colspan="1" rowspan="1">5.847</td><td colspan="1" rowspan="1">5.896</td><td colspan="1" rowspan="1">5.899</td><td colspan="1" rowspan="1">6.688</td><td colspan="1" rowspan="1">6.742</td><td colspan="1" rowspan="1">6.733</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="2">CL</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">90.61</td><td colspan="1" rowspan="1">90.89</td><td colspan="1" rowspan="1">90.46</td><td colspan="1" rowspan="1">101.81</td><td colspan="1" rowspan="1">102.29</td><td colspan="1" rowspan="1">101.71</td><td colspan="1" rowspan="1">112.79</td><td colspan="1" rowspan="1">113.09</td><td colspan="1" rowspan="1">112.46</td><td colspan="1" rowspan="1">130.18</td><td colspan="1" rowspan="1">130.35</td><td colspan="1" rowspan="1">129.65</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="2" rowspan="3">Control in urine</td><td colspan="3" rowspan="2">Control N</td><td colspan="3" rowspan="2">Control P</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="6" rowspan="8"></td></tr><tr><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td></tr><tr><td colspan="1" rowspan="2">NA</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">85.75</td><td colspan="1" rowspan="1">86.68</td><td colspan="1" rowspan="1">86.65</td><td colspan="1" rowspan="1">178.97</td><td colspan="1" rowspan="1">179.04</td><td colspan="1" rowspan="1">178.09</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.4</td></tr><tr><td colspan="1" rowspan="2">K</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">31.102</td><td colspan="1" rowspan="1">31.160</td><td colspan="1" rowspan="1">31.104</td><td colspan="1" rowspan="1">83.437</td><td colspan="1" rowspan="1">83.453</td><td colspan="1" rowspan="1">83.115</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.4</td></tr><tr><td colspan="1" rowspan="1">CL</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">62.04</td><td colspan="1" rowspan="1">62.48</td><td colspan="1" rowspan="1">66.09</td><td colspan="1" rowspan="1">163.60</td><td colspan="1" rowspan="1">162.67</td><td colspan="1" rowspan="1">171.54</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="2" rowspan="2">Patient samplein urine</td><td colspan="2" rowspan="1">Low sample</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Mic</td><td colspan="2" rowspan="1">Middle sample</td><td colspan="3" rowspan="1">High sample</td><td colspan="3" rowspan="1">Spiked sample</td></tr><tr><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td><td colspan="1" rowspan="1">Lot1</td><td colspan="1" rowspan="1">Lot2</td><td colspan="1" rowspan="1">Lot3</td></tr><tr><td colspan="1" rowspan="2">NA</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">27.69</td><td colspan="1" rowspan="1">28.44</td><td colspan="1" rowspan="1">28.36</td><td colspan="1" rowspan="1">103.54</td><td colspan="1" rowspan="1">104.24</td><td colspan="1" rowspan="1">103.53</td><td colspan="1" rowspan="1">188.09</td><td colspan="1" rowspan="1">187.72</td><td colspan="1" rowspan="1">186.54</td><td colspan="1" rowspan="1">336.99</td><td colspan="1" rowspan="1">334.35</td><td colspan="1" rowspan="1">331.45</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">1.0</td><td colspan="1" rowspan="1">0.8</td><td colspan="1" rowspan="1">1.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="2">K</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">29.373</td><td colspan="1" rowspan="1">29.309</td><td colspan="1" rowspan="1">29.176</td><td colspan="1" rowspan="1">68.765</td><td colspan="1" rowspan="1">68.922</td><td colspan="1" rowspan="1">68.365</td><td colspan="1" rowspan="1">118.831</td><td colspan="1" rowspan="1">118.845</td><td colspan="1" rowspan="1">118.050</td><td colspan="1" rowspan="1">220.783</td><td colspan="1" rowspan="1">221.125</td><td colspan="1" rowspan="1">218.953</td></tr><tr><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">0.5</td></tr><tr><td colspan="1" rowspan="1">CL</td><td colspan="1" rowspan="1">Mean value(mmol/L)</td><td colspan="1" rowspan="1">24.13</td><td colspan="1" rowspan="1">25.79</td><td colspan="1" rowspan="1">30.78</td><td colspan="1" rowspan="1">102.07</td><td colspan="1" rowspan="1">104.55</td><td colspan="1" rowspan="1">106.76</td><td colspan="1" rowspan="1">199.91</td><td colspan="1" rowspan="1">199.77</td><td colspan="1" rowspan="1">190.33</td><td colspan="1" rowspan="1">322.88</td><td colspan="1" rowspan="1">318.66</td><td colspan="1" rowspan="1">292.00</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">CV (%)</td><td colspan="1" rowspan="1">1.1</td><td colspan="1" rowspan="1">0.8</td><td colspan="1" rowspan="1">2.2</td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.8</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.6</td><td colspan="1" rowspan="1">0.4</td><td colspan="1" rowspan="1">0.3</td><td colspan="1" rowspan="1">0.3</td></tr></table>

2.2.2 Reproducibility (total precision) The Reproducibility was determined according to according to the CLSI guideline EP05-A3. 2 level controls, 3 samples of low, middle and high concentrations and the spiked samples were tested in duplicate for 20 days (2 series per day).

<table><tr><td rowspan=2 colspan=1>serum</td><td rowspan=1 colspan=2>NA in serum</td><td rowspan=1 colspan=2>K in serum</td><td rowspan=1 colspan=2>CL in serum</td></tr><tr><td rowspan=1 colspan=1>Mean value(mmol/L)</td><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>Mean value(mmol/L)</td><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>Mean value(mmol/L)</td><td rowspan=1 colspan=1>CV (%)</td></tr><tr><td rowspan=1 colspan=1>Control N</td><td rowspan=1 colspan=1>134.09</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>4.296</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>113.49</td><td rowspan=1 colspan=1>0.4</td></tr><tr><td rowspan=1 colspan=1>Control P</td><td rowspan=1 colspan=1>134.22</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>6.599</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>111.34</td><td rowspan=1 colspan=1>0.4</td></tr><tr><td rowspan=1 colspan=1>Control N2</td><td rowspan=1 colspan=1>122.41</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>3.814</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>90.77</td><td rowspan=1 colspan=1>0.4</td></tr><tr><td rowspan=1 colspan=1>Control P2</td><td rowspan=1 colspan=1>154.02</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>6.514</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>111.51</td><td rowspan=1 colspan=1>0.4</td></tr><tr><td rowspan=1 colspan=1>Low sample</td><td rowspan=1 colspan=1>126.47</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>2.800</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>90.25</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=1 colspan=1>Middle sample</td><td rowspan=1 colspan=1>139.09</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>4.058</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>101.59</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=1 colspan=1>High sample</td><td rowspan=1 colspan=1>148.82</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>5.861</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>112.36</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=1 colspan=1>Spiked sample</td><td rowspan=1 colspan=1>164.53</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>6.706</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>129.46</td><td rowspan=1 colspan=1>0.4</td></tr><tr><td rowspan=2 colspan=1>urine</td><td rowspan=1 colspan=2>NA in urine</td><td rowspan=1 colspan=2>K in urine</td><td rowspan=1 colspan=2>CL in urine</td></tr><tr><td rowspan=1 colspan=1>Mean value(mmol/L)</td><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>Mean value(mmol/L)</td><td rowspan=1 colspan=1>CV (%)</td><td rowspan=1 colspan=1>Mean value(mmol/L)</td><td rowspan=1 colspan=1>CV (%)</td></tr><tr><td rowspan=1 colspan=1>Control N</td><td rowspan=1 colspan=1>85.31</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>31.131</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>60.40</td><td rowspan=1 colspan=1>1.8</td></tr><tr><td rowspan=1 colspan=1>Control P</td><td rowspan=1 colspan=1>179.90</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>84.269</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>162.60</td><td rowspan=1 colspan=1>1.2</td></tr><tr><td rowspan=1 colspan=1>Low sample</td><td rowspan=1 colspan=1>27.93</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>29.388</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>24.29</td><td rowspan=1 colspan=1>3.1</td></tr><tr><td rowspan=1 colspan=1>Middle sample</td><td rowspan=1 colspan=1>103.29</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>68.638</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>100.79</td><td rowspan=1 colspan=1>0.7</td></tr><tr><td rowspan=1 colspan=1>High sample</td><td rowspan=1 colspan=1>187.18</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>117.706</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>199.13</td><td rowspan=1 colspan=1>0.4</td></tr><tr><td rowspan=1 colspan=1>Spiked sample</td><td rowspan=1 colspan=1>335.21</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>222.108</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>323.05</td><td rowspan=1 colspan=1>0.6</td></tr></table>

# 2.3 Interferences

This protocol was determined according to the CLSI EP07-A2.

The calculated bias was within the $10 \%$ acceptance criteria on Sodium, Potassium and Chloride serum and urine samples for up to the following concentrations.

<table><tr><td rowspan=1 colspan=2>NA, K, CL in serum</td><td rowspan=1 colspan=2>NA, K, CL in urine</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>1.25 g/dL</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>52.1 mmol/L</td><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>256 µmol/L</td></tr><tr><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>396 µmol/L</td><td rowspan=1 colspan=1>Protein</td><td rowspan=1 colspan=1>3.31 g/L</td></tr><tr><td rowspan=1 colspan=1>Total protein</td><td rowspan=1 colspan=1>121.13 g/L</td><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>988.3 mmol/L</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>71.9 mmol/L</td><td rowspan=1 colspan=1>Ascorbic acid</td><td rowspan=1 colspan=1>3.40 mmol/L</td></tr><tr><td rowspan=1 colspan=1>Salicylic acid</td><td rowspan=1 colspan=1>0.53mmol/L</td><td rowspan=6 colspan=2></td></tr><tr><td rowspan=1 colspan=1>Imipramine</td><td rowspan=1 colspan=1>2.50μmol/L</td></tr><tr><td rowspan=1 colspan=1>Procainamide</td><td rowspan=1 colspan=1>102μmol/L</td></tr><tr><td rowspan=1 colspan=1>Chlorpromazine</td><td rowspan=1 colspan=1>6.30μmol/L</td></tr><tr><td rowspan=1 colspan=1>Erythromycin</td><td rowspan=1 colspan=1>81.6μmol/L</td></tr><tr><td rowspan=1 colspan=1>Ampicillin</td><td rowspan=1 colspan=1>150 µmol/L</td></tr></table>

2.4 Matrix comparison on predicate device This protocol was according to the CLSI guideline EP09-A3.

Plasma samples were evaluated on Yumizen C1200 and Olympus AU400 Clinical Chemistry Analyzer. The equation for the regression line using Passing Bablok was obtained.

<table><tr><td rowspan=1 colspan=1>Passing Bablok</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Min (mmol/L)</td><td rowspan=1 colspan=1>Max (mmol/L)</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Correlation - r</td></tr><tr><td rowspan=1 colspan=1>NA</td><td rowspan=1 colspan=1>171</td><td rowspan=1 colspan=1>102.9</td><td rowspan=1 colspan=1>188.9</td><td rowspan=1 colspan=1>0.200</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.997</td></tr><tr><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>173</td><td rowspan=1 colspan=1>1.76</td><td rowspan=1 colspan=1>9.53</td><td rowspan=1 colspan=1>0.010</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>CL</td><td rowspan=1 colspan=1>173</td><td rowspan=1 colspan=1>53.1</td><td rowspan=1 colspan=1>178.4</td><td rowspan=1 colspan=1>-1.568</td><td rowspan=1 colspan=1>1.019</td><td rowspan=1 colspan=1>0.998</td></tr></table>

2.5 Method comparison with a reference device

Yumizen C1200 was compared with Olympus AU400 Clinical Chemistry Analyzer.

The patient samples were correlated with a commercial ISE module taken as reference according to the CLSI guideline EP09- A3.

The equation for the regression line using Passing Bablok was obtained.

<table><tr><td rowspan=1 colspan=1>PassingBablok</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Correlation - r</td></tr><tr><td rowspan=1 colspan=1>NA in serum</td><td rowspan=1 colspan=1>165</td><td rowspan=1 colspan=1>1.371</td><td rowspan=1 colspan=1>0.987</td><td rowspan=1 colspan=1>0.995</td></tr><tr><td rowspan=1 colspan=1>K in serum</td><td rowspan=1 colspan=1>170</td><td rowspan=1 colspan=1>0.023</td><td rowspan=1 colspan=1>0.994</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>CL in serum</td><td rowspan=1 colspan=1>172</td><td rowspan=1 colspan=1>0.818</td><td rowspan=1 colspan=1>0.992</td><td rowspan=1 colspan=1>0.998</td></tr><tr><td rowspan=1 colspan=1>NA in urine</td><td rowspan=1 colspan=1>194</td><td rowspan=1 colspan=1>-1.256</td><td rowspan=1 colspan=1>1.001</td><td rowspan=1 colspan=1>1.000</td></tr><tr><td rowspan=1 colspan=1>K in urine</td><td rowspan=1 colspan=1>198</td><td rowspan=1 colspan=1>-0.128</td><td rowspan=1 colspan=1>0.983</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>CL in urine</td><td rowspan=1 colspan=1>194</td><td rowspan=1 colspan=1>0.525</td><td rowspan=1 colspan=1>0.991</td><td rowspan=1 colspan=1>1.000</td></tr></table>

2.6 Electrodes Stability

The protocol of this study was followed by JEOL internal protocol.

The evaluation was performed using the same parameter checked in manufacturing of the electrodes.

2.6.1 Closed stability

Stable up to the expiry date on the label if stored at 0-40 degree C.

2.6.2 Open stability

Stable for 3 months from opened.

# 2.7 Reference Range

The Reference Range was determined according to the CLSI EP28-A3c.

80 normal samples (23 women $\yen 57$ men) in serum and plasma were assayed with the method in evaluation. Each sample was assayed in duplicates. The mean of the duplicate results for each subject was compared against reference ranges cited from literature. The verification studies supported in the following reference ranges which were established through literature. NA in serum and plasma: 136 to 145 mmol/L1

K in serum and plasma: 3.5 to 5.1 mmol/L1

(The reference range of K in plasma is about 0.5 mmol/L lower than in serum)2   
CL in serum and plasma: 98 to 107 mmol/L1

The expected values based on 24 hours urine out-put were cited from the literature.

K in urine: 25 to 125 mmol/day1

CL in urine: 110 to 250 mmol/day1

Reference:

1. Tietz NW, Clinical Guide for Laboratory Tests 3rd edition. WB Saunders Company, Philadelphia, PA, pp. 610-611(1995)   
2. Walker HK,et al. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition, Boston: Butterworths, pp   
884-887(1990)

# Non clinical tests

The non clinical studies tests conclude that the safety and effectiveness of the devices are not compromised.   
Yumizen C1200 meets the following.

<table><tr><td rowspan=1 colspan=1>ISO 14971: 2007</td><td rowspan=1 colspan=1>Medical devices - Application of risk management to medical devices</td></tr><tr><td rowspan=1 colspan=1>IEC 61326-2-6:2012</td><td rowspan=1 colspan=1>Electrical equipment for measurement, control and laboratory use — EMC requirements —Part 2-6: Particular requirements — In vitro diagnostic (IVD) medical equipment</td></tr><tr><td rowspan=1 colspan=1>IEC 61326-1: 2012</td><td rowspan=1 colspan=1>Electrical equipment for measurement, control and laboratory use - EMC requirements - Part1: General requirements</td></tr><tr><td rowspan=1 colspan=1>IEC 61010-1: 2010</td><td rowspan=1 colspan=1>Safety requirements for electrical equipment for measurement, control, and laboratory use-Part 1 General requirements</td></tr><tr><td rowspan=1 colspan=1>IEC 61010-2-010: 2014</td><td rowspan=1 colspan=1>Safety requirements for electrical equipment for measurement, control and laboratory use -Part 2-010: Particular requirements for laboratory equipment for the heating of materials</td></tr><tr><td rowspan=1 colspan=1>IEC 61010-2-101: 2015</td><td rowspan=1 colspan=1>Safety requirements for electrical equipment for measurement, control, and laboratory usePart 2-101: Particular requirements for in vitro diagnostic (IVD) medical equipment</td></tr><tr><td rowspan=1 colspan=1>IEC 62304: 2006</td><td rowspan=1 colspan=1>Medical device software — software life-cycle processes</td></tr><tr><td rowspan=1 colspan=1>IEC 60825-1 2014</td><td rowspan=1 colspan=1>Safety of laser products - Part 1: Equipment classification and requirements</td></tr></table>

# Conclusion

The data presented demonstrate that the Yumizen C1200 glucose, sodium, potassium, and chloride assays are substantially equivalent to the predicate devices.